Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-13 · accession 0000950170-25-021716 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-02-14 | 2025-02-13+ | AXSM | Pizzie Nick | CFO | M - OptEx | $3.50 | +15.0K | 45.2K | +50% | +$52.5K |
| DMT | 2025-02-14 | 2025-02-13+ | AXSM | Pizzie Nick | CFO | S - Sale+OE | $130.10 | -15.0K | 42.2K | -26% | -$1.95M |
| DMT | 2025-02-14 | 2025-02-13+ | AXSM | Pizzie Nick | CFO | M - OptEx | $3.50 | -15.0K | 0 | -100% | -$52.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-13 | M | A | 12,000 | $3.50 | 54,187 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | S | D | 3,000 | $131.07 | 42,187 | D | — | — | (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $130.06 and $131.72. |
| 3 | Common | Common Stock | 2025-02-14 | M | A | 3,000 | $3.50 | 45,187 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-13 | S | D | 12,000 | $129.86 | 42,187 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $128.50 and $131.64. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-02-13 | M | D | 12,000 | $3.50 | 0 | D | $3.50 · 2019-05-16 to 2028-05-16 | 12,000 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-02-14 | M | D | 3,000 | $3.50 | 0 | D | $3.50 · 2019-05-16 to 2028-05-16 | 3,000 Common Stock |